These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15722167)

  • 1. Intracellular targeting of polymer-bound drugs for cancer chemotherapy.
    Nori A; Kopecek J
    Adv Drug Deliv Rev; 2005 Feb; 57(4):609-36. PubMed ID: 15722167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells.
    Nori A; Jensen KD; Tijerina M; Kopecková P; Kopecek J
    Bioconjug Chem; 2003; 14(1):44-50. PubMed ID: 12526691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells.
    Nori A; Jensen KD; Tijerina M; Kopecková P; Kopecek J
    J Control Release; 2003 Aug; 91(1-2):53-9. PubMed ID: 12932637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.
    Al-Taei S; Penning NA; Simpson JC; Futaki S; Takeuchi T; Nakase I; Jones AT
    Bioconjug Chem; 2006; 17(1):90-100. PubMed ID: 16417256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear delivery of macromolecules: barriers and carriers.
    Belting M; Sandgren S; Wittrup A
    Adv Drug Deliv Rev; 2005 Feb; 57(4):505-27. PubMed ID: 15722161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
    Jones AT
    Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms.
    Futaki S
    Int J Pharm; 2002 Oct; 245(1-2):1-7. PubMed ID: 12270237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain.
    Lee KO; Luu N; Kaneski CR; Schiffmann R; Brady RO; Murray GJ
    Biochem Biophys Res Commun; 2005 Nov; 337(2):701-7. PubMed ID: 16223608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat peptide-mediated cellular delivery: back to basics.
    Brooks H; Lebleu B; Vivès E
    Adv Drug Deliv Rev; 2005 Feb; 57(4):559-77. PubMed ID: 15722164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
    Vives E
    J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
    Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
    Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAT transduction: the molecular mechanism and therapeutic prospects.
    Gump JM; Dowdy SF
    Trends Mol Med; 2007 Oct; 13(10):443-8. PubMed ID: 17913584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes.
    Hyndman L; Lemoine JL; Huang L; Porteous DJ; Boyd AC; Nan X
    J Control Release; 2004 Oct; 99(3):435-44. PubMed ID: 15451601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine-rich cell-penetrating peptides.
    Schmidt N; Mishra A; Lai GH; Wong GC
    FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
    Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
    J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-targeted polymeric drugs.
    Luo Y; Prestwich GD
    Curr Cancer Drug Targets; 2002 Sep; 2(3):209-26. PubMed ID: 12188908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.